Vicarious Surgical (RBOTW) Total Non-Current Liabilities (2020 - 2025)
Vicarious Surgical (RBOTW) reported Total Non-Current Liabilities of $14.7 million for Q3 2025, down 31.56% year-over-year from $21.5 million in Q3 2024, and down 13.43% quarter-over-quarter from $17.0 million in Q2 2025.
Vicarious Surgical (RBOTW) Total Non-Current Liabilities (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOTW) has 6 years of Total Non-Current Liabilities data on file, last reported at $14.7 million in Q3 2025.
- Total Non-Current Liabilities for Q3 2025 came in at $14.7 million, down 31.56% year-over-year; the trailing twelve-month figure through Sep 2025 was $14.7 million (down 31.56% YoY), and the FY2024 annual result was $20.2 million, down 3.94% from the prior year.
- Total Non-Current Liabilities fell to $14.7 million in Q3 2025 per RBOTW's latest filing, from $17.0 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $27.0 million in Q3 2022 and troughed at $5.4 million in Q3 2021.
- A 5-year average of $18.7 million and a median of $20.4 million in 2024 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities soared 396.12% in 2022, then sank 31.56% in 2025.
- A 5-year view of Total Non-Current Liabilities shows it stood at $8.6 million in 2021, then jumped by 171.1% to $23.2 million in 2022, then dropped by 9.3% to $21.1 million in 2023, then slipped by 3.94% to $20.2 million in 2024, then dropped by 27.32% to $14.7 million in 2025.
- Business Quant data shows RBOTW's Total Non-Current Liabilities at $14.7 million in Q3 2025, $17.0 million in Q2 2025, and $20.1 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 14.71 Mn |
| Jun 30, 2025 | 16.99 Mn |
| Mar 31, 2025 | 20.10 Mn |
| Dec 31, 2024 | 20.23 Mn |
| Sep 30, 2024 | 21.49 Mn |
| Jun 30, 2024 | 20.38 Mn |
| Mar 31, 2024 | 18.58 Mn |
| Dec 31, 2023 | 21.07 Mn |
| Sep 30, 2023 | 21.86 Mn |
| Jun 30, 2023 | 21.82 Mn |
| Mar 31, 2023 | 21.26 Mn |
| Dec 31, 2022 | 23.23 Mn |
| Sep 30, 2022 | 26.99 Mn |
| Jun 30, 2022 | 22.58 Mn |
| Mar 31, 2022 | 22.45 Mn |
| Dec 31, 2021 | 8.57 Mn |
| Sep 30, 2021 | 5.44 Mn |
| Jun 30, 2021 | 14.24 Mn |
| Mar 31, 2021 | 13.59 Mn |
| Dec 31, 2020 | -28.48 Mn |